What does RecoveryRx® cost?

I'll search for pricing and specification information on RecoveryRx® to build an evidence-based article. Based on my research, I need to inform you of a critical finding: RecoveryRx® is not a capital medical device that would generate procurement quotes in the traditional sense.

RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity.

The RecoveryRx® products last for 720 hours and can be turned on and off as needed. This means each unit is a disposable, single-use wearable device, not equipment that is purchased in capital format or leased by the facility.

The product is sold as consumable packs— Recovery Rx Postoperative Pain Therapy (1 Pack) units that adhere to wound sites and deliver therapy for 30 days before disposal. There is no publicly accessible retail pricing for bulk clinical purchase, and purchase of RecoveryRx® is only available to licensed medical professionals. If you are interested making a purchase, please find a RecoveryRx® distributor near you.

What This Means for Your Procurement Article

I cannot write a traditional price-estimate article for RecoveryRx® for these reasons:

1. No public pricing data: Unlike hospital beds, imaging equipment, or surgical devices, RecoveryRx pricing is not disclosed on manufacturer websites, GSA contracts, or distributor storefronts.

2. Distributor-only sales model: Purchase of RecoveryRx® is only available to licensed medical professionals. If you are intersted making a purchase, please find a RecoveryRx® distributor near you. Direct pricing requires contacting approved distributors.

3. Consumable, not capital equipment: This is a supply-chain item (similar to wound dressings or bandages with active elements), not a capital asset. The procurement logic is cost-per-unit and volume contracts, not equipment capex budgeting.

4. No lease or refurbishment market: Disposable wearables have no secondary market or rental options.

Recommendation

To proceed with a procurement-focused price article on RecoveryRx®, you would need to:

• Gather direct distributor quotes (MedSource would need to contact 3–5 approved distributors for list/contract pricing on bulk packs)
• Clarify the actual buyer segment: Are hospital surgery centers, wound clinics, or ASCs the target? This affects bulk pricing significantly.
• Establish a placeholder indicating that pricing is distributor-specific and will be updated once actual quotes accrue.

Would you like me to write a template article that acknowledges the distributor-only pricing model and invites readers to provide quote data, or would you prefer to first gather pricing from RecoveryRx distributors before commissioning the full piece?